Research priorities for rehabilitation and aging with HIV: a framework from the Canada-International HIV and Rehabilitation Research Collaborative (CIHRRC)

People with HIV are living longer and can experience physical, mental, and social health challenges associated with aging and multimorbidity. Rehabilitation is well-positioned to address disability and maximize healthy aging. In this article, findings from CIHRRC’s aim to identify emerging research priorities in HIV, aging, and rehabilitation from the perspectives of people living with HIV, clinicians, researchers, representatives from community organizations, and policy stakeholders are reported.

Maintaining HIV care during the COVID-19 pandemic

Weak healthcare systems have been exposed during the COVID-19 pandemic and challenges have arisen in regard to maintaining HIV care continuum during the COVID-19 pandemic. Particular efforts must focus on ensuring this care to avoid disruption of routine HIV services.

Geriatric syndromes in people living with HIV associated with aging and increasing comorbidities: implications for neurocognitive complications of HIV infection

Many aging people with HIV experience health effects similar to people who are 5-10 years older than them. This includes cognitive decline, something that is highly prevalent in older generations. Researchers look at the relationship between living with HIV and cognitive impairment. This article also addresses body composition changes in people with HIV and the clinical complications.

HIV and Aging in Mainland China: Implications for Control and Prevention 

The last 15 years have witnessed a dramatic change in HIV-related epidemiology amidst improvements in treatment and care in China. With proper treatment, HIV is now considered a chronic disease. As a consequence, many people living with HIV (PLWH) now present age-related comorbidities. Thirteen topical issues were reviewed concerning the epidemiology of aging with HIV in mainland China.

Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long-term suppressive antiretroviral therapy

This study evaluates the levels of systemic inflammation to better understand the risk of age-associated diseases in PLHIV on long-term suppressive ART using a large number of biomarkers of inflammation and immune activation. This study found that there is still a large amount of inflammation in those who are on ART as in those who were untreated.